
- March 2016 Central Nervous System
- Volume 82
- Issue 3
Naloxone Rescue: The Emerging Role of Pharmacists in Preventing Opioid Overdose
This Continuing Education activity is supported by an educational grant from Adapt Pharma.
This activity is supported by an educational grant from Adapt Pharma.
Faculty
Patrick Bridgeman, PharmD, BCPS
Clinical Assistant Professor
Ernest Mario School of Pharmacy
Department of Pharmacy Practice and Administration
Clinical Pharmacy Specialist
Emergency Medicine
Robert Wood Johnson University Hospital
New Brunswick, New Jersey
Editorial Support
Jeannette Y. Wick, RPh, MBA, FASCP
Freelance Medical Writer
Arlington, Virginia
Visiting Professor
University of Connecticut School of Pharmacy
Storrs, Connecticut
Educational Objectives
After completing this continuing education program, the participant will be able to:
- Examine the prevalence of opioid overdose and its implications for society.
- Explore strategies and legislation aimed at reducing the growth of opioid-related overdoses and identify at-risk patients to ensure these strategies are aimed at the right audience.
- Explain the mechanism of action of naloxone, its role as an opiate antagonist, and its safety and efficacy profile.
- Distinguish the differences between the intravenous, intramuscular/subcutaneous, and intranasal routes of administration for naloxone.
- Illustrate the pharmacist’s role in educating patients about naloxone, including the role of the pharmacist in dispensing naloxone without a prescription.
Target audience: Retail P
harmacists
Type of activity: Application
Release date: March 7, 2016
Expiration date: March 7, 2017
Estimated time to complete activity: 2.0 hours
Fee: Free
Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-16-020-H01-P. The activity is available for CE credit through March 7, 2018.
Articles in this issue
over 9 years ago
Latent Tuberculosis After the Use of Etanerceptover 9 years ago
Case Studies (March 2016)over 9 years ago
Can You Read These Rxs? (March 2016)over 9 years ago
Pet Peeves (March 2016)over 9 years ago
Our Voice: A Pharmacy Technician Journaling Initiativeover 9 years ago
Making a Difference Through Leadershipover 9 years ago
Heroin Abuse: How It Differs from Rx Drug AbuseNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.